Azelis enters Israel with Orklia buy
Submitted by:
Andrew Warmington
Azelis has extended its reach into Israel by acquiring Orkila Israel, a speciality chemicals distributor
CEFIC calls for EU recovery plan
Submitted by:
Andrew Warmington
Ahead of the European Council meeting on 17 July, CEFIC called on EU member states
CordenPharma in peptide expansion
Submitted by:
Andrew Warmington
CordenPharma has announced the addition of a 3,000-litre solid-phase peptide synthesis (SPPS) vessel at its
SOCMA report finds companies ‘bullish’
Submitted by:
Andrew Warmington
A new report by SOCMA and Vault Consulting, the Specialty Chemicals Industry Census, has found
Evotec initiates ‘Campus Curie’ in Toulouse
Submitted by:
Andrew Warmington
Drug discovery firm Evotec, which also owns the CDMO Aptuit, has acquired the ‘Biopark by Sanofi’
Covid-19: Four more events postponed
Submitted by:
Andrew Warmington
At the end of June, three more major exhibitions that attract high attendances from the
Carlyle Group invests in Piramal
Submitted by:
Andrew Warmington
Via CA Clover Intermediate II Investments, private equity firm the Carlyle Group is to invest
Nouryon completes two moves
Submitted by:
Andrew Warmington
Nouryon has completed two recently announced advances: the acquisition of the carboxymethyl cellulose (CMC) business
Clariant continues speciality drive
Submitted by:
Andrew Warmington
Clariant has taken what exective chairman Hariold Kottmann (above) called “another significant step
Bayer resolves most Monsanto litigation
Submitted by:
Andrew Warmington
Bayer has made a series of agreements that, it said, “will substantially resolve” major outstanding